Join
Live feed
·
PRReleasevia Quantisnow
Augmedix Inc. logo

Augmedix Exits Calendar 2022 with Expected $35 Million in Annual Recurring Revenue

ByQuantisnow·Wall Street's wire, on your screen.
AUGX· Augmedix Inc.
Consumer Discretionary

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track AUGX (Augmedix Inc.) and more on Quantisnow.